Current approach to hemochromatosis P Brissot, MB Troadec, E Bardou-Jacquet, C Le Lan, AM Jouanolle, ... Blood reviews 22 (4), 195-210, 2008 | 197 | 2008 |
Iron disorders of genetic origin: a changing world P Brissot, E Bardou-Jacquet, AM Jouanolle, O Loréal Trends in molecular medicine 17 (12), 707-713, 2011 | 110 | 2011 |
Effect of alcohol consumption on liver stiffness measured by transient elastography E Bardou-Jacquet, L Legros, D Soro, M Latournerie, A Guillygomarc’h, ... World journal of gastroenterology: WJG 19 (4), 516, 2013 | 108 | 2013 |
Heterozygous mutations in BMP6 pro-peptide lead to inappropriate hepcidin synthesis and moderate iron overload in humans R Daher, C Kannengiesser, D Houamel, T Lefebvre, E Bardou-Jacquet, ... Gastroenterology 150 (3), 672-683. e4, 2016 | 100 | 2016 |
A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload C Kannengiesser, AM Jouanolle, G Hetet, A Mosser, F Muzeau, D Henry, ... haematologica 94 (3), 335, 2009 | 99 | 2009 |
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group S Pape, RJ Snijders, TJG Gevers, O Chazouilleres, GN Dalekos, ... Journal of hepatology 76 (4), 841-849, 2022 | 97 | 2022 |
Dysmetabolic iron overload syndrome (DIOS) Y Deugnier, É Bardou-Jacquet, F Lainé La Presse Médicale 46 (12), e306-e311, 2017 | 94 | 2017 |
Iron, hepcidin, and the metal connection O Loréal, T Cavey, E Bardou-Jacquet, P Guggenbuhl, M Ropert, P Brissot Frontiers in pharmacology 5, 128, 2014 | 90 | 2014 |
Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis E Bardou-Jacquet, J Morcet, G Manet, F Lainé, M Perrin, AM Jouanolle, ... Journal of hepatology 62 (3), 682-689, 2015 | 88 | 2015 |
Sex and acquired cofactors determine phenotypes of ferroportin disease C Le Lan, A Mosser, M Ropert, L Detivaud, V Loustaud–Ratti, ... Gastroenterology 140 (4), 1199-1207. e2, 2011 | 76 | 2011 |
Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis E Bardou‐Jacquet, J Philip, R Lorho, M Ropert, M Latournerie, ... Hepatology 59 (3), 839-847, 2014 | 72 | 2014 |
Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients F Lainé, M Ruivard, V Loustaud‐Ratti, F Bonnet, P Calès, ... Hepatology 65 (2), 465-474, 2017 | 69 | 2017 |
Non-invasive measurement of liver iron concentration using 3-Tesla magnetic resonance imaging: validation against biopsy G d’Assignies, A Paisant, E Bardou-Jacquet, A Boulic, E Bannier, F Lainé, ... European radiology 28, 2022-2030, 2018 | 67 | 2018 |
Non-HFE hemochromatosis: pathophysiological and diagnostic aspects E Bardou-Jacquet, ZB Ali, MP Beaumont-Epinette, O Loréal, ... Clinics and research in hepatology and gastroenterology 38 (2), 143-154, 2014 | 64 | 2014 |
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis M De Tayrac, MP Roth, AM Jouanolle, H Coppin, G Le Gac, A Piperno, ... Journal of Hepatology 62 (3), 664-672, 2015 | 61 | 2015 |
A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload E Bardou-Jacquet, ML Island, AM Jouanolle, L Détivaud, N Fatih, ... Blood Cells, Molecules, and Diseases 47 (4), 243-248, 2011 | 59 | 2011 |
Acoustic radiation force impulse imaging for assessing liver fibrosis in alcoholic liver disease A Kiani, V Brun, F Lainé, B Turlin, J Morcet, S Michalak, A Le Gruyer, ... World journal of gastroenterology 22 (20), 4926, 2016 | 55 | 2016 |
Revisiting hemochromatosis: genetic vs. phenotypic manifestations GJ Anderson, E Bardou-Jacquet Annals of translational medicine 9 (8), 2021 | 54 | 2021 |
Non‐invasive assessment of liver fibrosis in C282Y homozygous HFE hemochromatosis L Legros, E Bardou‐Jacquet, M Latournerie, A Guillygomarc'h, B Turlin, ... Liver International 35 (6), 1731-1738, 2015 | 52 | 2015 |
Twenty years of ferroportin disease: a review or an update of published clinical, biochemical, molecular, and functional features LT Vlasveld, R Janssen, E Bardou-Jacquet, H Venselaar, H Hamdi-Roze, ... Pharmaceuticals 12 (3), 132, 2019 | 49 | 2019 |